For: | Adler M, Taylor S, Okebugwu K, Yee H, Fielding C, Fielding G, Poles M. Intrahepatic natural killer T cell populations are increased in human hepatic steatosis. World J Gastroenterol 2011; 17(13): 1725-1731 [PMID: 21483633 DOI: 10.3748/wjg.v17.i13.1725] |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v17/i13/1725.htm |
Number | Citing Articles |
1 |
Mikhaïl A. Van Herck, Jonas Weyler, Wilhelmus J. Kwanten, Eveline L. Dirinck, Benedicte Y. De Winter, Sven M. Francque, Luisa Vonghia. The Differential Roles of T Cells in Non-alcoholic Fatty Liver Disease and Obesity. Frontiers in Immunology 2019; 10 doi: 10.3389/fimmu.2019.00082
|
2 |
Carlos Cuño-Gómiz, Estefanía de Gregorio, Anna Tutusaus, Patricia Rider, Nuria Andrés-Sánchez, Anna Colell, Albert Morales, Montserrat Marí. Sex-based differences in natural killer T cell-mediated protection against diet-induced steatohepatitis in Balb/c mice. Biology of Sex Differences 2023; 14(1) doi: 10.1186/s13293-023-00569-w
|
3 |
Nazarena E. Ferreyra Solari, María Eugenia Inzaugarat, Placida Baz, Elena De Matteo, Carol Lezama, Marcela Galoppo, Cristina Galoppo, Alejandra C. Cherñavsky. The Role of Innate Cells Is Coupled to a Th1-Polarized Immune Response in Pediatric Nonalcoholic Steatohepatitis. Journal of Clinical Immunology 2012; 32(3): 611 doi: 10.1007/s10875-011-9635-2
|
4 |
Melissa Bedard, Dilip Shrestha, David A. Priestman, Yuting Wang, Falk Schneider, Juan D. Matute, Shankar S. Iyer, Uzi Gileadi, Gennaro Prota, Matheswaran Kandasamy, Natacha Veerapen, Gurdyal Besra, Marco Fritzsche, Sebastian Zeissig, Andrej Shevchenko, John C. Christianson, Frances M. Platt, Christian Eggeling, Richard S. Blumberg, Mariolina Salio, Vincenzo Cerundolo. Sterile activation of invariant natural killer T cells by ER-stressed antigen-presenting cells. Proceedings of the National Academy of Sciences 2019; 116(47): 23671 doi: 10.1073/pnas.1910097116
|
5 |
Zahra Moayedfard, Farnaz Sani, Aliakbar Alizadeh, Kamran Bagheri Lankarani, Mohammad Zarei, Negar Azarpira. The role of the immune system in the pathogenesis of NAFLD and potential therapeutic impacts of mesenchymal stem cell-derived extracellular vesicles. Stem Cell Research & Therapy 2022; 13(1) doi: 10.1186/s13287-022-02929-6
|
6 |
Shasha Zhu, Huimin Zhang, Li Bai. NKT cells in liver diseases. Frontiers of Medicine 2018; 12(3): 249 doi: 10.1007/s11684-018-0622-3
|
7 |
Julia Nilsson, Maria Hörnberg, Anja Schmidt-Christensen, Kajsa Linde, Maria Nilsson, Marine Carlus, Saskia F. Erttmann, Sofia Mayans, Dan Holmberg. NKT cells promote both type 1 and type 2 inflammatory responses in a mouse model of liver fibrosis. Scientific Reports 2020; 10(1) doi: 10.1038/s41598-020-78688-2
|
8 |
Luisa Vonghia, Sven Francque. Cross talk of the immune system in the adipose tissue and the liver in non-alcoholic steatohepatitis: Pathology and beyond. World Journal of Hepatology 2015; 7(15): 1905-1912 doi: 10.4254/wjh.v7.i15.1905
|
9 |
Grigorios Papadopoulos, Eirini Giannousi, Aikaterini P. Avdi, Rallia-Iliana Velliou, Polyxeni Nikolakopoulou, Antonios Chatzigeorgiou. Τ cell-mediated adaptive immunity in the transition from metabolic dysfunction-associated steatohepatitis to hepatocellular carcinoma. Frontiers in Cell and Developmental Biology 2024; 12 doi: 10.3389/fcell.2024.1343806
|
10 |
Antonios Chatzigeorgiou, Triantafyllos Chavakis. Metabolic Control. Handbook of Experimental Pharmacology 2015; 233: 221 doi: 10.1007/164_2015_8
|
11 |
Azalia Mariel Carranza-Trejo, Vaclav Vetvicka, Lucie Vistejnova, Milena Kralickova, Edgar B. Montufar. Hepatocyte and immune cell crosstalk in non-alcoholic fatty liver disease. Expert Review of Gastroenterology & Hepatology 2021; 15(7): 783 doi: 10.1080/17474124.2021.1887730
|
12 |
Igor Maricic, Idania Marrero, Akiko Eguchi, Ryota Nakamura, Casey D. Johnson, Suryasarathi Dasgupta, Carolyn D. Hernandez, Phirum Sam Nguyen, Austin D. Swafford, Rob Knight, Ariel E. Feldstein, Rohit Loomba, Vipin Kumar. Differential Activation of Hepatic Invariant NKT Cell Subsets Plays a Key Role in Progression of Nonalcoholic Steatohepatitis. The Journal of Immunology 2018; 201(10): 3017 doi: 10.4049/jimmunol.1800614
|
13 |
Luisa Vonghia, Peter Michielsen, Sven Francque. Immunological Mechanisms in the Pathophysiology of Non-Alcoholic Steatohepatitis. International Journal of Molecular Sciences 2013; 14(10): 19867 doi: 10.3390/ijms141019867
|
14 |
Lucy Petagine, Mohammed Gulrez Zariwala, Vinood B Patel. Non-alcoholic fatty liver disease: Immunological mechanisms and current treatments. World Journal of Gastroenterology 2023; 29(32): 4831-4850 doi: 10.3748/wjg.v29.i32.4831
Abstract(491) |
Core Tip(543) |
Full Article(HTML)(4466)
|
Full Article with Cover (PDF)-7927K(129)
|
Full Article (Word)-2109K(63)
|
Audio-1055K(9)
|
Peer-Review Report-223K(75)
|
Answering Reviewers-111K(68)
|
Full Article (PDF)-7683K(329)
|
Full Article (XML)-377K(65)
|
Times Cited (14)
|
Total Visits (8014)
|
Open
|
15 |
Kazuto Tajiri, Yukihiro Shimizu. Role of NKT Cells in the Pathogenesis of NAFLD. International Journal of Hepatology 2012; 2012: 1 doi: 10.1155/2012/850836
|
16 |
Bin Gao, Svetlana Radaeva. Natural killer and natural killer T cells in liver fibrosis. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease 2013; 1832(7): 1061 doi: 10.1016/j.bbadis.2012.09.008
|
17 |
Alvaro Santos-Laso, María Gutiérrez-Larrañaga, Marta Alonso-Peña, Juan M. Medina, Paula Iruzubieta, María Teresa Arias-Loste, Marcos López-Hoyos, Javier Crespo. Pathophysiological Mechanisms in Non-Alcoholic Fatty Liver Disease: From Drivers to Targets. Biomedicines 2021; 10(1): 46 doi: 10.3390/biomedicines10010046
|
18 |
Moritz Meyer, Julian Schwärzler, Almina Jukic, Herbert Tilg. Innate Immunity and MASLD. Biomolecules 2024; 14(4): 476 doi: 10.3390/biom14040476
|
19 |
Xiao-Yu Luo, Terumi Takahara, Kengo Kawai, Masayuki Fujino, Toshiro Sugiyama, Koichi Tsuneyama, Kazuhiro Tsukada, Susumu Nakae, Liang Zhong, Xiao-Kang Li. IFN-γ deficiency attenuates hepatic inflammation and fibrosis in a steatohepatitis model induced by a methionine- and choline-deficient high-fat diet. American Journal of Physiology-Gastrointestinal and Liver Physiology 2013; 305(12): G891 doi: 10.1152/ajpgi.00193.2013
|
20 |
Jordi Yang Zhou. Innate immunity and early liver inflammation. Frontiers in Immunology 2023; 14 doi: 10.3389/fimmu.2023.1175147
|
21 |
Maria Papanastasatou, Mihalis Verykokakis. Innate-like T lymphocytes in chronic liver disease. Frontiers in Immunology 2023; 14 doi: 10.3389/fimmu.2023.1114605
|
22 |
Anna Janina Engstler, Cathrin Sellmann, Cheng Jun Jin, Annette Brandt, Kathleen Herz, Josephine Priebs, Ina Bergheim. Treatment with alpha‐galactosylceramide protects mice from early onset of nonalcoholic steatohepatitis: Role of intestinal barrier function. Molecular Nutrition & Food Research 2017; 61(5) doi: 10.1002/mnfr.201600985
|
23 |
Alexander Wree, Lori Broderick, Ali Canbay, Hal M. Hoffman, Ariel E. Feldstein. From NAFLD to NASH to cirrhosis—new insights into disease mechanisms. Nature Reviews Gastroenterology & Hepatology 2013; 10(11): 627 doi: 10.1038/nrgastro.2013.149
|
24 |
Atsuko Imai, Eka Fujimoto, Kaho Tamura, Masanori Utsuyama, Kazuto Sato. A maternal high-fat diet may accelerate adipo-immunologic aging in offspring. Life Sciences 2019; 219: 100 doi: 10.1016/j.lfs.2019.01.008
|
25 |
Shuwen Liang, Tonya Webb, Zhiping Li. Probiotic antigens stimulate hepatic natural killer T cells. Immunology 2014; 141(2): 203 doi: 10.1111/imm.12180
|
26 |
Tianyu Mao, Rui Yang, Yi Luo, Kang He. Crucial role of T cells in NAFLD-related disease: A review and prospect. Frontiers in Endocrinology 2022; 13 doi: 10.3389/fendo.2022.1051076
|
27 |
Ludmila V. Topchieva, Irina V. Kurbatova, Olga P. Dudanova, Alina V. Vasileva, Galina A. Zhulai. Immune cell balance as potential biomarker of progressing non-alcoholic fatty liver disease. Genes & Cells 2024; 19(1): 105 doi: 10.17816/gc610252
|
28 |
M. Noureddin, Q. M. Anstee, R. Loomba. Review article: emerging anti‐fibrotic therapies in the treatment of non‐alcoholic steatohepatitis. Alimentary Pharmacology & Therapeutics 2016; 43(11): 1109 doi: 10.1111/apt.13620
|
29 |
Yongyan Chen, Zhigang Tian. Innate lymphocytes: pathogenesis and therapeutic targets of liver diseases and cancer. Cellular & Molecular Immunology 2021; 18(1): 57 doi: 10.1038/s41423-020-00561-z
|
30 |
Jie Huang, Meng Li, Wen-Jun Zhoua, Ze-Min Yao, Guang Ji, Li Zhang, Ming-Zhe Zhu. Integrated miRNA and mRNA Analysis Identified Potential Mechanisms and Targets of Qianggan Extracts in Preventing Nonalcoholic Steatohepatitis. World Journal of Traditional Chinese Medicine 2022; 8(1): 77 doi: 10.4103/wjtcm.wjtcm_48_21
|
31 |
Lipeng Cheng, Li Geng, Binghua Dai, Tao Zheng, Jun Fu, Liang Qiao, Wenchang Cai, Yue Wang, Jiamei Yang. Repression of let-7a cluster prevents adhesion of colorectal cancer cells by enforcing a mesenchymal phenotype in presence of liver inflammation. Cell Death & Disease 2018; 9(5) doi: 10.1038/s41419-018-0477-1
|
32 |
Patricia Lamadrid, Marta Alonso-Peña, David San Segundo, Mayte Arias-Loste, Javier Crespo, Marcos Lopez-Hoyos. Innate and Adaptive Immunity Alterations in Metabolic Associated Fatty Liver Disease and Its Implication in COVID-19 Severity. Frontiers in Immunology 2021; 12 doi: 10.3389/fimmu.2021.651728
|
33 |
Patrice Marques, Vera Francisco, Laura Martínez-Arenas, Ângela Carvalho-Gomes, Elena Domingo, Laura Piqueras, Marina Berenguer, Maria-Jesus Sanz. Overview of Cellular and Soluble Mediators in Systemic Inflammation Associated with Non-Alcoholic Fatty Liver Disease. International Journal of Molecular Sciences 2023; 24(3): 2313 doi: 10.3390/ijms24032313
|
34 |
Katherine Schwenger, Lina Chen, Adeline Chelliah, Hannah Da Silva, Anastasia Teterina, Elena Comelli, Amel Taibi, Bianca Arendt, Sandra Fischer, Johane Allard. Markers of activated inflammatory cells are associated with disease severity and intestinal microbiota in�adults with non‑alcoholic fatty liver disease. International Journal of Molecular Medicine 2018; doi: 10.3892/ijmm.2018.3800
|
35 |
Jie Huang, Meng Li, Wen-Jun Zhoua, Ze-Min Yao, Guang Ji, Li Zhang, Ming-Zhe Zhu. Integrated miRNA and mRNA analysis identified potential mechanisms and targets of qianggan extracts in preventing nonalcoholic steatohepatitis. World Journal of Traditional Chinese Medicine 2022; 8(1): 77 doi: 10.4103/2311-8571.335135
|
36 |
Koji Murono, Joji Kitayama, Nelson H. Tsuno, Hiroaki Nozawa, Kazushige Kawai, Eiji Sunami, Masaaki Akahane, Toshiaki Watanabe. Hepatic steatosis is associated with lower incidence of liver metastasis from colorectal cancer. International Journal of Colorectal Disease 2013; 28(8): 1065 doi: 10.1007/s00384-013-1656-2
|
37 |
Yongyan Chen, Zhigang Tian. Roles of Hepatic Innate and Innate-Like Lymphocytes in Nonalcoholic Steatohepatitis. Frontiers in Immunology 2020; 11 doi: 10.3389/fimmu.2020.01500
|
38 |
Andrew D. Clouston, Victoria L. Gadd, Katharine M. Irvine, Elizabeth E. Powell. New Paradigms in the Histopathology of NAFLD. Current Hepatology Reports 2014; 13(2): 81 doi: 10.1007/s11901-014-0214-x
|
39 |
Ki-Jeong Park, Hye-Mi Jin, Young-Nan Cho, Jae Hyun Yoon, Seung-Jung Kee, Hyo-Sin Kim, Yong-Wook Park. Altered Frequency, Activation, and Clinical Relevance of Circulating Innate and Innate-Like Lymphocytes in Patients With Alcoholic Liver Cirrhosis. Immune Network 2023; 23(3) doi: 10.4110/in.2023.23.e22
|